From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant Treatment

Abstract excerpt

OBJECTIVE: Major depressive disorder is the most common psychiatric disorder, worldwide, yet response and remission rates are still unsatisfactory. The identification of genetic predictors of antidepressant (AD) response could provide a promising opportunity to improve current AD efficacy through the personalization of treatment. The major steps and findings along this path are reviewed together with their...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Associations and Epidemiology
• Share to Neurotransmitter Receptor Influence on Behavior
• Share to Treatment of Major Depression